Results 11 to 20 of about 100,300 (318)

Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions

Biomolecules, 2019
Drug-eluting stents (DES) have been widely applied for saving the life of patients with coronary artery diseases (CADs). However, conventional polymers such as polylactic acid (PLA) and poly (lactic-co-glycolic acid) (PLGA), which are widely applied for ...
Ruixia Hou, Leigang Wu, Jin Wang, Zhilu Yang, Qiufen Tu, Xingcai Zhang, Nan Huang   +6 more
doaj   +2 more sources

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +2 more sources

Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.

JAMA Neurology, 2022
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after intracranial stenting in patients who were treated with a standard bare-metal stent (BMS).
Baixue Jia, Xuelei Zhang, N. Ma, D. Mo, F. Gao, Xuan Sun, Ligang Song, Lian Liu, Yiming Deng, Xiaotong Xu, Yong Zhang, Zengpin Liu, S. Guan, Fan Zhang, Bing Li, Hongbo Zheng, Xinfeng Liu, Yajie Liu, Kangning Chen, Jie Shuai, J. Wan, Jun Wang, Xiang-fei Shi, Tianxiao Li, Binge Chang, D. Liebeskind, Wengui Yu, Z. Miao   +27 more
semanticscholar   +1 more source

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Circulation. Cardiovascular Quality and Outcomes, 2021
Supplemental Digital Content is available in the text. Background: There is increasing evidence that use of intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) is associated with improved clinical outcomes compared ...
Jennifer Y. Zhou, D. Liew, S. Duffy, J. Shaw, A. Walton, W. Chan, R. Gerber, D. Stub   +7 more
semanticscholar   +1 more source

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence

Journal of Clinical Medicine, 2023
Iterations in stent technologies, advances in pharmacotherapy, and awareness of the implications of implantation techniques have markedly reduced the risk of stent failure, both in the form of stent thrombosis (ST) and in-stent restenosis (ISR). However,
F. Condello, C. Spaccarotella, S. Sorrentino, C. Indolfi, G. Stefanini, A. Polimeni   +5 more
semanticscholar   +1 more source

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas, Hoffmann, Rainer, Köster, Ralf, Pohl, Tilmann   +5 more
core   +2 more sources

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy

Case Reports in Medicine, 2009
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term from those of bare-metal stents, late stent thrombosis after deployment of drug-eluting stents has emerged as a potential safety concern in the era of high-
Dirk Sibbing, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, Jürgen Pache   +3 more
doaj   +1 more source

The future of drug eluting stents [PDF]

Heart, 2005
In-stent restenosis (ISR) is the major drawback of percutaneous coronary interventions, occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority of patients in preventing restenosis for the first year after implantation.
Anis, RR, Karsch, KR
openaire   +3 more sources

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

SAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita, Kenya Nasu, Mitsuyasu Terashima, Tsuyoshi Ito, Tomomitsu Tani, Takahiko Suzuki, Nobuyuki Ohte   +6 more
doaj   +1 more source

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon- expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial [PDF]

, 2002
BACKGROUND: The goal of this intravascular ultrasound investigation was to provide a more detailed morphological analysis of the local biological effects of the implantation of a sirolimus-eluting stent compared with an uncoated stent.
Abizaid, A.C. (Alexandre), Colombo, A. (Antonio), Degertekin, M. (Muzaffer), Feyter, P.J. (Pim) de, Guagliumi, G. (Giulio), Ligthart, J.M.R. (Jürgen), Lindeboom, W.K. (Wietze), Morice, M-C. (Marie-Claude), Serruys, P.W.J.C. (Patrick), Sousa, J.E. (Eduardo), Tanabe, K. (Kengo), Wijns, W. (William)   +11 more
core   +1 more source